01 FLUDEOXYGLUCOSE F-18 (2)
01 FEINSTEIN (2)
01 INJECTABLE;INTRAVENOUS (2)
01 20-200mCi/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** (1)
02 20-400mCi/ML (1)
01 USA (2)
19
Feinstein Institutes, based in U.S.A, is a pharmaceutical company.
One of their notable products is FLUDEOXYGLUCOSE F-18, with a corresponding application number 21870 and regulatory information .
proudly manufactured in the
approval since 2008-11-21
Feinstein Institutes's FLUDEOXYGLUCOSE F18 INJECTABLE;INTRAVENOUS, medication with 20-400mCi/ML of FLUDEOXYGLUCOSE F-18.
18
Feinstein Institutes, based in U.S.A, is a pharmaceutical company.
One of their notable products is FLUDEOXYGLUCOSE F-18, with a corresponding application number 21870 and regulatory information .
proudly manufactured in the
approval since 2005-08-19
Feinstein Institutes's FLUDEOXYGLUCOSE F18 INJECTABLE;INTRAVENOUS, medication with 20-200mCi/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** of FLUDEOXYGLUCOSE F-18.